TMZ is the first‐line chemotherapeutic for glioma treatment, inducing DNA damage.[28] Interestingly, spatial atlas of GBM showed that relative higher DNA repair signaling in spots of CDC20+KIF20A+PTTG1+ glioma cell subpopulation (Figure S4G, Supporting Information). This evidence concerns the gene PTTG1 and central nervous system cancer.